6677.TWO Anxo Pharmaceutical Co., Ltd.

Healthcare Drug Manufacturers - Specialty & Generic Taiwan OTC Exchange
21.10 TWD
Close of Nov 6, 2026
15.50 25.30
Market cap
TWD 1.18B
P/E
-
P/B
1.21x
ROE
-3.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6677.TWO undervalued?

Graham number

The Graham number of Anxo Pharmaceutical Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Anxo Pharmaceutical Co., Ltd. fundamental analysis

No fundamental analysis for Anxo Pharmaceutical Co., Ltd. yet.

Anxo Pharmaceutical Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Anxo Pharmaceutical Co., Ltd.

Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. The company offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. It also offers drugs for antidiabetic/dyslipidaemic agents, car…

Full company profile